This ADC product is comprised of an anti-SDC1 monoclonal antibody (nBT062) conjugated via a SPP linker to a DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cel
* VAT and and shipping costs not included. Errors and price changes excepted